Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension
| Status: | Archived |
|---|---|
| Conditions: | High Blood Pressure (Hypertension), Ocular |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Ophthalmology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | December 2010 |
| End Date: | March 2012 |
This study will evaluate the ocular surface tolerability of the prostaglandin analogues
bimatoprost ophthalmic solution 0.01% (Lumigan® 0.01%), travoprost ophthalmic solution
0.004% (Travatan Z®) and latanoprost ophthalmic solution 0.005% (Xalatan®) in patients
previously treated with Xalatan® who have open-angle glaucoma or ocular hypertension.
We found this trial at
1
site
Click here to add this to my saved trials
